Dr William John Tanski Iii, MD | |
250 Pleasant St, Concord, NH 03301-7539 | |
(603) 226-6122 | |
Not Available |
Full Name | Dr William John Tanski Iii |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 26 Years |
Location | 250 Pleasant St, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568564524 | NPI | - | NPPES |
1018403 | Medicaid | VT | |
3073783 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 13519 (New Hampshire) | Primary |
208600000X | Surgery | 13519 (New Hampshire) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
Alice Peck Day Memorial Hospital | Lebanon, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Entity Name | Dartmouth-hitchcock Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386697803 PECOS PAC ID: 4183537509 Enrollment ID: O20031111000313 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Entity Name | Mary Hitchcock Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Entity Name | Dartmouth-hitchcock Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Entity Name | Alliance Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891859419 PECOS PAC ID: 8022019215 Enrollment ID: O20070131000394 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William John Tanski Iii, MD 250 Pleasant St, Concord, NH 03301-7539 Ph: (603) 226-6122 | Dr William John Tanski Iii, MD 250 Pleasant St, Concord, NH 03301-7539 Ph: (603) 226-6122 |
News Archive
More than 1000 people packed into the Basilique Notre-Dame today in Geneva to attend the funeral of Dr LEE Jong-wook, Director-General of the World Health Organization.
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types-the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles-that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer - among the most confusing and controversial dilemmas in health care.
The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.
› Verified 8 days ago
Dr. Joseph Robert Snow, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Suite 1350, Concord, NH 03301 Phone: 603-230-1970 Fax: 603-230-1971 | |
Marc Anthony Camacho, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St., Memorial Building, West, Ground Floor, Concord, NH 03301 Phone: 603-415-6400 Fax: 603-227-7595 | |
Anne C. Granfield, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St Ste 205, Concord, NH 03301 Phone: 603-224-0584 Fax: 603-227-7560 | |
Dr. Michael Daniel Paul, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St Ste 205, Concord, NH 03301 Phone: 603-224-0584 | |
Dr. Patrick William Mannal, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 2800, Concord, NH 03301 Phone: 603-224-5200 Fax: 603-227-7559 | |
Dr. Eric Michael Dyson, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Memorial Building, West, Ground Floor, Concord, NH 03301 Phone: 603-415-6400 Fax: 603-227-7595 | |
Dr. Michael James Wood, M.D., M.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-229-5114 |